08 GSK Annual Report 2018 Key performance indicators Our 10 operating key performance indicators KPIs track progress On this page we provide performance data for the operating KPIs against our long-term priorities.
They measure how we are performing we are reporting externally.
Due to commercial sensitivities we are at an overall Group level and across our three businesses.
They are not planning to publish data for all operating KPIs.
reviewed regularly by our Corporate Executive Team and the Board, We use a number of adjusted, non-IFRS, measures to report the and employees are updated on progress every quarter.
In 2018, we performance of our business, as described on pages 40 to 42, launched a new performance system to align employees bonuses including Adjusted results, free cash flow and CER growth rates.
to a relevant subset of our ten KPIs.
The remuneration policy used Non-IFRS measures may be considered in addition to, but not as to reward the performance of our executives includes measures a substitute for or superior to, information presented in accordance linked to our KPIs see pages 97, 101 and 103. with IFRS.
Innovation 2018 growth 2018 2017 2016 bn % CER% bn bn Innovation sales R a a Sales of Pharmaceuticals and Vaccines products launched in the last five years 5.7 43 46 4.0 2.6 For internal purposes we also measure pipeline value and progress.
Performance 2018 growth 2018 2017 2016 % CER% bn bn bn R 30.8 2 5 30.2 27.9 Group turnover Operating profit and margin R Total operating profit 5.5 34 43 4.1 2.6 8.7 2 6 8.6 7.7 Adjusted operating profit Total margin 17.8% 13.5% 9.3% 28.4% 28.4% 27.5% Adjusted margin b b R 5.7 63 3.5 3.3 Free cash flow For internal purposes we also measure market share, and top talent in key roles.
Trust 2018 2017 2016 Employee engagement Employee engagement scores from our global employee survey 78 79 For internal purposes we also measure supply service levels and corporate reputation.
R Linked to Executive LTI awards and bonus, see pages 97, 101 and 103. a Comparative information reflects sales of those products that meet the definition for 2018. b Revised to include proceeds from the sale of intangible assets.
